Khalifa Kush has become the top-selling celebrity cannabis brand in the United States by doing what most celebrity entrepreneurs didn't: turning down the big upfront check.
While fellow celebrities rushed to license their names to cannabis companies for immediate payouts, Wiz Khalifa's brand took a different path. The decision came a decade ago when the industry was young and money was flowing freely. Most celebrity brands from that era are now defunct or struggling.
The licensing model that dominated celebrity cannabis in the mid-2010s was simple. A company would pay a celebrity millions upfront to use their name, then handle all operations while the celebrity collected royalties. It looked like easy money. But the model had a fatal flaw: celebrities had little control over quality, distribution, or business decisions. When those licensed products failed to meet consumer expectations or the companies behind them collapsed, the celebrity brands went down with them.
Khalifa Kush chose equity over immediate cash. The brand maintained operational control and built relationships directly with cultivators and retailers. This meant slower growth and no seven-figure signing bonus, but it also meant the brand could ensure product quality and adapt to market changes.
The Numbers
After ten years in operation, Khalifa Kush has outlasted nearly every celebrity cannabis brand from its era. The brand operates across multiple state markets and has expanded beyond flower into concentrates, pre-rolls, and vapes. Specific sales figures weren't disclosed, but the brand's longevity in a market littered with failed celebrity ventures speaks to the model's success.
The contrast is stark. Brands that took licensing deals in 2015 and 2016 often saw their partner companies go bankrupt or get acquired, leaving the celebrity with little recourse. Khalifa Kush's equity position meant the brand could weather industry downturns and maintain consistent operations.
What This Means for Celebrity Brands
The cannabis industry has seen a dramatic shift in how celebrity partnerships work. Early deals were structured like traditional endorsements: pay the celebrity, use their image, hope for sales. But cannabis proved different. Consumers wanted authenticity and consistent quality, not just a famous name on a package.
Khalifa Kush's approach required more work upfront. The brand had to build cultivation partnerships, negotiate with dispensaries, and manage product development. But that hands-on involvement created a brand that could survive market consolidation and changing consumer preferences.
Other celebrity brands have since adopted similar models, taking smaller upfront payments in exchange for equity and operational input. The shift reflects a maturing industry where celebrity names alone don't guarantee success.
Looking Ahead
The brand's ten-year milestone comes as the celebrity cannabis space enters a new phase. Federal rescheduling discussions and interstate commerce possibilities could reshape how brands operate nationally. Khalifa Kush's existing infrastructure and market presence position it differently than newer celebrity entrants.
For cannabis entrepreneurs considering celebrity partnerships, the Khalifa Kush model offers a template. Equity-based deals with operational involvement create alignment between the celebrity and the business. Licensing deals create quick revenue but little staying power.
The brand's success also highlights a broader industry truth: in cannabis, long-term thinking beats short-term cash grabs. The companies and brands that survived the past decade's boom-and-bust cycles were the ones that built real operations, not just marketing campaigns.
This article is based on original reporting by hightimes.com.
